ASO Author Reflections: Patient-Reported Outcomes—Bench to Bedside

Abstract

Historically, oncology trials have focused on quantitative parameters: mortality, recurrence, and short-term morbidity. In recent years, there has been a trend toward obtaining patient perspective through systematic tracking of electronic patient reported outcomes. PRO-CTCAE, a companion to CTCAE that measures symptomatic toxicity from the patient perspective, has been developed and validated and is publicly available for use in multiple languages. Recent oncology clinical trials that have utilized PROs have demonstrated reduced acute care utilization and symptom burden, as well as improved survival. It has now become imperative to translate and integrate PROs into everyday oncology clinical practice.